ESTABLISHMENT LABS HOLDINGS INC. (ESTA) stock: key figures, P/E, revenue and dividend
Health Care · Costa Rica · ISIN USG312491081
ESTABLISHMENT LABS HOLDINGS INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 211.08 m USD |
| Gross profit | 146.31 m USD |
| Operating income | -39.01 m USD |
| EBIT | -33.19 m USD |
| Net income | -51.06 m USD |
| Diluted EPS – continuing operations | -1.72 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ESTABLISHMENT LABS HOLDINGS INC.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
More stocks
- Hebei Huatong Wires and Cables Group Co. Ltd. (605196.SS)
- Aberforth Smaller Companies Trust PLC (ASL.L)
- Atea ASA (ATEA.OL)
- Genus PLC (GNS.L)
- Nanjing Sunlord Electronics Corporation LTD (300975.SZ)
- Colt CZ Group SE (CZG.PR)
- Siltronic (WAF.DE)
- IDT CORP (IDT)
- Wuhu Token Sciences (300088.SZ)
- Taiflex Scientific Co Ltd (8039.TW)
- Sarepta Therapeutics, Inc. (SRPT)
- Shenglan Technology Co Ltd (300843.SZ)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.